RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Tumor-Specific Immunity Induced by Cryoablation in a Murine Renal Cell Carcinoma Model

      한글로보기

      https://www.riss.kr/link?id=A104589106

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge mo...

      Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge model.
      Materials and Methods: Sixty BALB/c mice with RENCA tumors that were generated in the left flank area underwent cryoablation or radical excision. The mice successfully treated were rechallenged with RENCA or an undifferentiated colon carcinoma cell line, CT26, in the contralateral right flank area. The recurrence rate after tumor rechallenge in each group was then observed. To assess the immunologic response of each treatment modality, fluorescent-activated cell sorting (FACS) analysis and a cytotoxicity assay using 51Cr release were performed.
      Results: After reinoculation of the RENCA cells, the rate of tumor growth was significantly higher in the surgical excision group than in the cryoablation group (94.4% vs. 11.1%, p=0.001). In the cryoablation group, the tumor growth rate was significantly increased after rechallenge of CT26 cells compared with RENCA (94.1% vs. 11.1%, p=0.001). The cryoablation group showed an elevated CD3, CD4, CD8 T, and natural killer cell count in the FACS analysis and also showed significantly increased cytotoxicity in the 51Cr release assay compared with the excision group.
      Conclusions: These results showed that cryoablation, compared to surgical resection, was more effective in preventing tumor growth after rechallenge with RENCA cells and that this response was tumor-specific, because the CT26 cells did not have the same effect.

      더보기

      참고문헌 (Reference)

      1 Abhinav Sidana, "Urologic Applications of Cryo-Immunology" 대한비뇨기과학회 50 (50): 629-634, 2009

      2 Onik GM, "Ultrasound characteristics of renal cryosurgery" 42 : 212-215, 1993

      3 deKernion JB, "Treatment of advanced renal cell carcinoma: traditional methods and innovative approaches" 130 : 2-7, 1983

      4 Hoffmann NE, "The cryobiology of cryosurgical injury" 60 (60): 40-49, 2002

      5 Osada S, "Serum cytokine levels in response to hepatic cryoablation" 95 : 491-498, 2007

      6 Soanes WA, "Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations" 104 : 154-159, 1970

      7 Rabinovitch RA, "Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy" 12 : 206-212, 1994

      8 Oosterwijk E, "Monoclonal antibody-based therapy for renal cell carcinoma" 30 : 623-631, 2003

      9 Aron M, "Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy" 51 : 348-357, 2007

      10 Neel HB 3rd, "Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation" 11 : 45-52, 1979

      1 Abhinav Sidana, "Urologic Applications of Cryo-Immunology" 대한비뇨기과학회 50 (50): 629-634, 2009

      2 Onik GM, "Ultrasound characteristics of renal cryosurgery" 42 : 212-215, 1993

      3 deKernion JB, "Treatment of advanced renal cell carcinoma: traditional methods and innovative approaches" 130 : 2-7, 1983

      4 Hoffmann NE, "The cryobiology of cryosurgical injury" 60 (60): 40-49, 2002

      5 Osada S, "Serum cytokine levels in response to hepatic cryoablation" 95 : 491-498, 2007

      6 Soanes WA, "Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations" 104 : 154-159, 1970

      7 Rabinovitch RA, "Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy" 12 : 206-212, 1994

      8 Oosterwijk E, "Monoclonal antibody-based therapy for renal cell carcinoma" 30 : 623-631, 2003

      9 Aron M, "Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy" 51 : 348-357, 2007

      10 Neel HB 3rd, "Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation" 11 : 45-52, 1979

      11 Playfair JH, "Immunology at a glance" Blackwell 70-71, 2005

      12 Matin SF, "Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model" 183 : 333-338, 2010

      13 Eskandari H, "Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy" 20 : 872-874, 1982

      14 Sabel MS, "Immunologic response to cryoablation of breast cancer" 90 : 97-104, 2005

      15 Lubaroff DM, "Immunologic aspects of the prostate" 2 : 233-248, 1981

      16 Johnson JP, "Immunologic aspects of cryosurgery: potential modulation of immune recognition and effector cell maturation" 8 : 39-47, 1990

      17 Udagawa M, "Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation" 12 : 7465-7475, 2006

      18 Mabjeesh NJ, "Emerging nephron sparing treatments for kidney tumors: a continuum of modalities from energy ablation to laparoscopic partial nephrectomy" 171 (171): 553-560, 2004

      19 Ablin RJ, "Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate" 2 : 276-279, 1973

      20 Skinner DG, "Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases" 28 : 1165-1177, 1971

      21 Gage AA, "Cryosurgery for oral and pharyngeal carcinoma" 118 : 669-672, 1969

      22 Abbas AK, "Cellular and molecular immunology" Elsevier 2004

      23 Jacobsohn KM, "Adjuvant therapy for renal cell carcinoma" 33 : 576-582, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-03-12 학회명변경 한글명 : 대한비뇨기과학회 -> 대한비뇨의학회 KCI등재
      2016-03-04 학술지명변경 외국어명 : 미등록 -> Investigative and Clinical Urology KCI등재
      2016-01-15 학술지명변경 한글명 : Korean Journal of Urology -> Investigative and Clinical Urology KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-02-21 학술지명변경 한글명 : 대한비뇨기과학회지 -> Korean Journal of Urology
      외국어명 : The Korean Journal of Urology -> 미등록
      KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.14 0.14 0.13
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.12 0.314 0.23
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼